MarketScreener Editorial Features Genmab A/S
Stocks
GMAB
DK0010272202
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,616.50 DKK | +0.53% |
|
+2.08% | -20.25% |
| 04:57pm | Genmab Says Subgroup Data for Follicular Lymphoma Treatment Shows 'Sustained' Efficacy Benefits | MT |
| 06-10 | Nordic stocks in North America - Autoliv rose 1.6 percent | FW |
MarketScreener Editorial Features
Search
 | Weekly Earnings Calendar: Palantir, AMD, AXA and Engie in the Spotlight | May 04, 2026 at 10:21 am |
| Weekly Earnings Calendar: Palantir, AMD, AXA and Engie in the Spotlight | May 04, 2026 at 10:18 am |
 | Genmab: From now on, courage to the most patient | April 01, 2025 at 03:57 pm |
 | New entries in MarketScreener's Europe portfolio | August 05, 2024 at 09:47 am |
 | New entries in MarketScreener's Europe portfolio | December 08, 2023 at 11:02 am |
 | Analyst recommendations: Charter Communications, Chevron, Match Group, Shopify, Spotify... | May 02, 2022 at 01:02 pm |
No results match your criteria
Filters
- Stock Market
- Stocks
- GMAB Stock
- News Genmab A/S
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
